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Abstract
This editorial introduces a new special series on intervention development in the on-line open access journal Pilot and
Feasibility Studies. An intervention development study reports the rationale, decision-making processes, methods and
findings which occur between the idea or inception of an intervention until it is ready for formal feasibility, pilot or
efficacy testing prior to a full trial or evaluation. This editorial begins to explore some of the challenges associated with
this early research stage. It commences a debate about how to produce novel interventions which are fit for purpose
and which solve important health and social care problems. By transparently reporting more intervention development
studies, scientific rigour will be improved and everyone can learn from the experiences of others.
Intervention development can be viewed as a “black box”
or the “Cinderella” of complex intervention trial design.
This is because important processes and decision-making
in the early stages of intervention development are seldom
reported and until now, journals have shown little interest
in publishing such studies. Intervention development
studies exist in small grant reports and PhD chapters and
tend to gather dust on the shelf as researchers move on to
secure larger grants and new projects. So anecdotally,
researchers encounter recurring pitfalls, spend time in
blind alleys and worry about intervention decisions, with
little guidance available. In addition, until recently, UK
research funding institutions have not prioritised invest-
ment in complex intervention development.
The importance of methodological rigour at this early
stage is recognised [1], and there is research waste from
developing interventions that never impact on health
care [2]. With ageing populations, multi-morbidity and
lifestyle behaviours that seem remarkably resistant to
change effective interventions are needed. In this special
series, we begin to open the black box of intervention
development. We are particularly interested in complex
interventions, where there are several interacting com-
ponents, rather than drugs or invasive devices which
have regulated development processes.
How are intervention development studies
defined?
A working definition of an intervention development
study for this special series is
A study that describes the rationale, decision making
processes, methods and findings which occur between
the idea or inception of an intervention until it is
ready for formal feasibility, pilot or efficacy testing
prior to a full trial or evaluation.
Put simply, it is a study about the what, why, how and
when decisions involved in specifying an intervention, so
that it can be replicated with fidelity by others. This is
sometimes called an “intervention manual” which is pro-
spectively written prior to a trial and includes any training
required to deliver the intervention. This is a working
definition of intervention development studies because
there is remarkably little literature. Definitions and use of
language are crucial. The UK National Institute of Health
Research (NIHR) glossary does not define an intervention
development study per se, but defines an intervention as
The process of intervening on people, groups, entities
or objects in an experimental study. In controlled
trials, the word is sometimes used to describe the
regimens in all comparison groups, including placebo
and no-treatment arms [3].
It could be argued that the tail is wagging the dog
(rather than the dog wagging its tail) in that intervention
development studies are now likely to be shaped by the
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TIDieR guidance which aims to improve the systematic
reporting of interventions [4].
There is a grey area around overlap with and definitions
of feasibility studies. The NIHR definition of a feasibility
study is “Can this study be done?” and expects that
A robust case be made for the plausibility of the
intervention and clinical importance of any
subsequent full trial [3].
Applying this definition, feasibility can apply within an
intervention development study as described by Murray
and colleagues in this issue [5] e.g. can these compo-
nents work together? Are they likely to be summative,
synergistic or detract? Feasibility can also apply to the
operational aspects of trial design (e.g. recruitment,
engagement, retention and outcome assessment) which
do not feature in an intervention manual. The examples
provided by Yardley and colleagues in this issue [6] make
a strong case for assessing aspects of operational feasi-
bility right from the start of intervention development.
An extension of CONSORT guidelines for pilot and
feasibility studies is in progress and this has given rise to
much debate about the definitions of pilot and feasibility
studies [7]. For example, the scope of the Medical
Research Council (MRC) Public Health Intervention De-
velopment funding scheme [8] includes research to inform
sample size, power calculations, and estimates of recruit-
ment and retention which are usually assessed in a formal
pilot or feasibility study.
What do we know about intervention
development studies?
Little is known about the number of intervention develop-
ment studies that are tested in a formal pilot, proceed to a
full evaluation and are implemented into routine practice.
From 101 reports of new medical discoveries, over-
optimism was evident as only one led to the development
of an intervention that was widely used [9]. Optimistic
bias is therefore important in intervention development
studies. Assessing operational bias in systematic reviews is
routine [10], and there are particular issues for assessing
bias in behaviour change trials [11], but less attention has
been paid to bias when developing an intervention.
What strategies might help to identify and reduce
optimistic bias? Karl Popper proposed the discipline of
falsification in the scientific method and the importance
of challenging all knowledge, by proactively seeking to
disconfirm it [12]. From thousands of observations of
swans in the UK, you would conclude that all swans are
white. Searching in unexpected places is required to find
the black swan. Daniel Kahneman states overconfidence
as endemic in medicine and describes the planning
fallacy, where plans are unrealistically close to best case
scenarios [13]. Kahneman recommends gaining an out-
side view, for example by examining statistical data
from similar projects. Others highlight the importance
of qualitative methods and triangulation approaches to
critique or validate quantitative data and provide a per-
sonal perspective [14].
Groupthink [15] is where cognitively homogeneous
groups have strong allegiances, tend not to voice dissent,
rationalise away counterarguments and are confident in
their plans. What happens within groups is complex [16],
and strategies to avoid groupthink in the early stages of
trial design have received little attention. Research teams
and expert panels can benefit from selecting independent
thinkers [17] to be the critical friend, the dragon in the
den or devil’s advocate. Citation bias, where research
teams with prestige are disproportionately cited, can be a
problem which contributes to research waste [18]. Group-
think can result in premature conceptual closure, the col-
lection and reporting of confirming data only and for
“assumption habits” or blind spots to be unrecognised. A
recent example is where a dominant behaviour change
theory, the theory of planned behaviour, has underpinned
interventions for three decades and is no longer consid-
ered valid [19]. It provides valuable insights into how un-
expected findings can be attributed to operational flaws
rather than questioning the validity of the theory itself. It
can be argued, therefore, that methods which tend to-
wards consensus (e.g. focus groups; Delphi techniques)
are only appropriate when finalising an intervention
specification.
Sampling, location and context bias should be consid-
ered, regardless of the methods used to develop an
intervention. For example, when designing smartphone
applications, sampling and location decisions can influ-
ence the data collected about the intervention use [20].
Certain groups or settings may not be included e.g.
ethnic minorities, rural communities. Convenience
sampling bias is where participants or settings overtly
or covertly have something in common which limits
generalizability. This may be unavoidable when resources
are limited and can be accounted for in later pilot testing.
Constructing a diversity sampling matrix [21] and using
several interviewers from different disciplines to minimise
interviewer bias are useful strategies to increase the range
of perspectives. Proactively challenging and testing as-
sumptions with follow-up of any counter-intuitive findings
are important.
Intervention development is seldom a fixed
prospective linear process
It is apparent that isolating intervention development as
a stand-alone research stage, study or report may not be
appropriate. Even in pilot trials, defined as a “smaller
version of the main study used to test whether the
Hoddinott Pilot and Feasibility Studies  (2015) 1:36 Page 2 of 4
components of the main study can all work together” [3],
further tinkering with the intervention may be warranted
prior to a full trial. This is because health service con-
texts vary, change and interact with complex interven-
tions in many different ways [22]. Unlike the constant
enclosed environment of a petri dish for introducing
new antibiotics into a microbe culture—interventions
where human relationships form a significant part are
dynamic and vulnerable to unexpected events. The
meanings attributed to the intervention by people and
the accompanying visuals, emotions and narrative are
well recognised in commercial product development [5]
but have been relatively neglected in health research.
Innovation approaches are changing [23]. In the human
computer interaction field, an intervention needs to con-
stantly adapt to rapid innovation and a cyclical, iterative
approach is recommended for generating hypotheses for
mini tests [20, 24]. Mini tests or pilots generate data that
can validate decisions and challenge critical assumptions
at an earlier stage and quickly when developing an inter-
vention [23]. This contrasts with more labour-intensive
approaches where extensive modelling and theory gen-
eration precede any testing. Rapid validation mini tests
can overcome one of the limitations of qualitative re-
search in intervention development: when people are
asked about hypothetical interventions, they can say
what they find acceptable, need or want, but their
subsequent actions can be quite different [23]. More
tangible mini-testing processes within the intended
intervention context have some parallels to action re-
search [25] and quality improvement approaches like
the plan-do-study-act cycle [26].
What guidance is available?
The Medical Research Council guidance for complex inter-
ventions does not define an intervention development
study per se but poses helpful questions for researchers [1].
In Table 1, I propose adaptations to the MRC Guidance
questions to reflect more recent literature and debate.
Questions 1–3 are unchanged. The TIDieR guidelines
are incorporated into question 4. Question 5 is
reworded to reflect the absence, heterogeneity or inad-
equate reporting of interventions in systematic reviews.
Strategies for intervention synthesis to select the “best
bets” when translating systematic review evidence into
intervention development are proposed [27]. Novel
intervention development may be justified, for example
when a series of null trials in a particular context is
counter to the international systematic review evidence
[28], or existing interventions may have limited reach
for particular groups, for example the uptake of weight
loss interventions by men compared to women [29].
Question 6 is reworded to consider future implementa-
tion barriers and facilitators for both a full trial and
translation into routine care. Question 7 is new and asks
the following: has the potential for bias been considered?
It proposes optimistic bias, group think, sampling, loca-
tion and context biases as important examples.
There are many challenges ahead for intervention
development studies. How do the academic community
and policy makers weigh up the pros and cons of “slow
research” versus efficient designs? How do research
teams make the myriad of small decisions to finalise
intervention manuals, particularly when systematic re-
view evidence is lacking? How do traditional graded evi-
dence [27], inductive, deductive and abductive logic
[30], tacit and explicit knowledge [31], fast and slow
thinking [13] and creativity contribute to intervention
development? How can methods and decision-making
processes be reported in a rigorous scientific and trans-
parent way? How useful would checklists or frame-
works be when commercial technology companies like
Google (see https://research.google.com/) achieve rapid
innovation with impact through flexibility?
Moving forward
This series commences a debate which involves the
research community, patients, clinicians, the public,
charities and anyone with an interest in developing the
best possible interventions for health and wellbeing. It
aims to raise the profile and value of intervention devel-
opment research, to open the black box and begin to
unpack the experiences, methods, processes and out-
comes. This will help to promote cross-disciplinary
learning and stimulate debate about how to produce
novel interventions to solve important health and social
care problems. Intervention development is where cre-
ativity, science and art meet and the balance is delicate.
Future qualitative synthesis of intervention development
studies could have the potential to illuminate why early
Table 1 Questions for researchers about intervention
development adapted from the MRC Complex Intervention
guidance [1]
1. Are you clear about what you are trying to do, what outcome you
are aiming for, and how you will bring about change?
2. Does your intervention have a coherent theoretical basis?
3. Have you used this theory systematically to develop the intervention?
4. Can you describe the intervention fully according to TIDieR guidelines
[4], so that it can be implemented properly for the purposes of your
evaluation and replicated by others?
5. Does the existing evidence [or lack of evidence]—ideally collated in a
systematic review—support the development of your intervention so
that it is likely to be feasible, effective and cost effective?
6. Has future implementation in multi-centre research settings and fu-
ture translation into the real world been considered?
7. Has the potential for bias been considered e.g. optimistic bias, group
think, sampling, location and context bias?
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intervention promise so often disappears, resulting in re-
search waste. Imperative are the principles of high-quality
scientific reporting and rigour, with descriptions of how
patients, the public, clinicians, relevant staff and policy
makers are involved in the decision-making processes.
Transparent reporting of both successes and failures is
crucial.
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